Lymphoma & CLL Cancer Translational Research Disease Group

Understanding the genetic alterations that lead to lymphoma/cll cancer is essential to fighting the disease. At Fox Chase, a multidisciplinary team of researchers and clinicians meets regularly to review translational research initiatives to identify and characterize new biomarkers of lymphoma/cll cancer that lead to new, innovative prevention and targeted therapy options for our patients.